Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

Share Price is delayed by 15 minutes
Get Live Data
20.05    0.69 (3.56%)
Bid:
19.88
Ask:
20.05
Spread: 0.17 (0.855%)
Market Cap: £373.15m
ENQ Live PriceLast checked at - London Stock Exchange

Intraday Enquest Share Chart

Form 8.3 - Enquest PLC

29 Apr 2025 15:00

RNS Number : 6759G
American Century Invest. Mgmnt Inc
29 April 2025
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

American Century Investment Management, Inc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

EnQuest plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

28/04/2025

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Β 

No

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

USD .01 Common

Β 

Β 

Interests

Short positions

Β 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

23,973,150

Β 

1.29%

0

0%

(2) Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Β 

Β 

Β 

Β 

Β 

TOTAL:

23,973,150

Β 

1.29%

0

0%

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Β 

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

5p Ordinary

Purchase

42,994

.1381

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

29/04/2025

Contact name:

Stefan Giglione

Telephone number*:

816-340-4720

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETPKCBPNBKDOQB
Date   Source Headline
22nd Oct 20187:00 amRNSResult of Rights Issue
4th Oct 20187:00 amRNSMagnus and Thistle Options exercised
2nd Oct 20183:12 pmRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAdmission of Nil Paid Rights
1st Oct 20182:55 pmRNSResults of General Meeting
25th Sep 20187:00 amRNSSwedish Issue Price
24th Sep 20181:43 pmRNSDirector/PDMR Shareholding
7th Sep 20187:00 amRNSMagnus Acquisition and Rights Issue
7th Sep 20187:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSKraken FPSO settlement agreement
31st Jul 20182:17 pmRNSNotice to holders of the Company's Retail Notes
7th Jun 201811:24 amRNSReport on Payments to Govts
24th May 20184:39 pmRNSResult of AGM
24th May 20187:00 amRNSOperations Update
27th Apr 20184:37 pmRNSDirector/PDMR Shareholding
24th Apr 20182:27 pmRNSDirector/PDMR Shareholding
19th Apr 20184:00 pmRNSNotice of AGM and Report & Accounts
29th Mar 20188:57 amRNSDirector/PDMR Shareholding
20th Mar 20187:00 amRNSFull Year Results
21st Feb 20183:56 pmRNSAdmission to Trading
19th Feb 20187:00 amRNSOperations Update
16th Feb 20184:51 pmRNSReplacement: Released in Error
15th Feb 20189:07 amRNSPublication of Final Terms
31st Jan 20187:00 amRNSAGREEMENT WITH BP ON THISTLE DECOMMISSIONING
29th Jan 201810:22 amRNSNotice to holders of the Company's Retail Notes
25th Jan 20183:34 pmRNSHolding(s) in Company
10th Jan 20183:59 pmRNSTotal Voting Rights
8th Jan 20187:00 amRNSBoard Appointment
11th Dec 20177:00 amRNSDirectorate Change
1st Dec 20177:00 amRNSCompletion of Acquisition
30th Nov 20177:00 amRNSOperational Update
26th Oct 20177:00 amRNSLiquidity enhanced by over $100 million
24th Oct 201710:51 amRNSAllotment and Listing of Shares
26th Sep 20173:02 pmRNSDirector/PDMR Shareholding
22nd Sep 201712:58 pmRNSPublication of a Prospectus
13th Sep 20173:48 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSBoard Appointment
7th Sep 20177:00 amRNSHalf Year Results
23rd Aug 20177:00 amRNSOperations update
31st Jul 20174:34 pmRNSNotice to holders of the Company's Retail Notes
29th Jun 20179:00 amRNSDirectorate Change
26th Jun 20177:00 amRNSKraken First Oil
21st Jun 20174:14 pmRNSReport on Payments to Govts
25th May 20174:44 pmRNSBoard Appointment
25th May 20174:39 pmRNSResult of AGM
25th May 20177:00 amRNSOperational Update
15th May 20174:02 pmRNSPublication of a Prospectus
25th Apr 201711:20 amRNSDirector/PDMR Shareholding
19th Apr 20174:10 pmRNSNotice of AGM and Report & Accounts
21st Mar 20174:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.